Point72 Hong Kong’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-688
Closed -$6.82K 448
2025
Q2
$6.82K Sell
688
-375
-35% -$3.67K ﹤0.01% 413
2025
Q1
$9.98K Buy
+1,063
New +$11.2K ﹤0.01% 424
2022
Q4
Sell
-610
Closed -$12K 145
2022
Q3
$12K Sell
610
-215
-26% -$4.72K ﹤0.01% 1692
2022
Q2
$16K Sell
825
-845
-51% -$17.3K ﹤0.01% 1596
2022
Q1
$36K Buy
+1,670
New +$37.9K ﹤0.01% 1418
2021
Q4
Sell
-1,728
Closed -$45K 1862
2021
Q3
$45K Buy
1,728
+483
+39% +$12.9K ﹤0.01% 1545
2021
Q2
$34K Buy
+1,245
New +$30.4K ﹤0.01% 1545
2020
Q1
Sell
-788
Closed -$13K 934
2019
Q4
$13K Buy
+788
New +$12K ﹤0.01% 955

Other funds holding ANGO

Point72 Hong Kong's ANGO Position: Q3 2025 in Review

Point72 Hong Kong sold out of AngioDynamics (ANGO) in Q3 2025, closing a stake of 688 shares — an estimated $6.82K sold.

Point72 Hong Kong first reported a position in ANGO in Q4 2019 and held it in 8 quarters. The position peaked at $45K in Q3 2021. 144 funds tracked by Wall St. Rank hold ANGO as of Q3 2025.

  • Point72 Hong Kong reported no remaining AngioDynamics position as of Q3 2025 after selling out during the quarter.
  • Point72 Hong Kong sold 688 AngioDynamics shares in Q3 2025, an estimated $6.82K.
  • Point72 Hong Kong first reported a position in AngioDynamics in Q4 2019 and held it in 8 quarters.
  • Point72 Hong Kong's AngioDynamics position peaked at $45K in Q3 2021.
  • 144 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2025.

Based on Point72 Hong Kong's 13F filing for Q3 2025, filed 14 Nov 2025.